Page de couverture de A New Era of Presbyopia Drop Therapy

A New Era of Presbyopia Drop Therapy

A New Era of Presbyopia Drop Therapy

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

 Blake Williamson, MD, MPH, invites Steven Dell, MD, to discuss the recent release of a new presbyopia drop—VIZZ (aceclidine ophthalmic solution, 1.44%; Lenz Therapeutics). Dr. Dell outlines why this drop represents a game-changing option for presbyopia therapy. The once-daily drop lasts for 10 hours and results in a sub-2-mm pupil size to achieve significant gains in near vision. They also review the innovation cycle of this product and how patients have responded to the treatment so far.
Pas encore de commentaire